Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

SELL
$95.06 - $111.52 $5,228 - $6,133
-55 Reduced 2.33%
2,305 $0
Q3 2022

Oct 11, 2022

BUY
$96.76 - $112.03 $228,353 - $264,390
2,360 New
2,360 $239,000
Q2 2021

Jul 13, 2021

SELL
$105.79 - $124.53 $373,756 - $439,964
-3,533 Closed
0 $0
Q1 2021

Apr 12, 2021

BUY
$108.84 - $128.23 $2,176 - $2,564
20 Added 0.57%
3,533 $423,000
Q4 2020

Jan 12, 2021

SELL
$105.0 - $114.42 $32,235 - $35,126
-307 Reduced 8.04%
3,513 $384,000
Q3 2020

Oct 08, 2020

SELL
$91.64 - $111.29 $120,964 - $146,902
-1,320 Reduced 25.68%
3,820 $415,000
Q2 2020

Jul 09, 2020

SELL
$76.57 - $98.0 $575,959 - $737,156
-7,522 Reduced 59.41%
5,140 $469,000
Q1 2020

Apr 08, 2020

SELL
$62.82 - $91.86 $4,711 - $6,889
-75 Reduced 0.59%
12,662 $1.01 Million
Q4 2019

Jan 10, 2020

BUY
$78.51 - $87.4 $19,234 - $21,413
245 Added 1.96%
12,737 $1.1 Million
Q3 2019

Oct 11, 2019

BUY
$81.84 - $88.74 $445,455 - $483,011
5,443 Added 77.22%
12,492 $1.05 Million
Q2 2019

Jul 24, 2019

SELL
$72.88 - $85.0 $178,701 - $208,420
-2,452 Reduced 25.81%
7,049 $593,000
Q1 2019

Apr 04, 2019

BUY
$66.22 - $80.06 $52,115 - $63,007
787 Added 9.03%
9,501 $760,000
Q4 2018

Feb 05, 2019

SELL
$65.56 - $74.27 $59,462 - $67,362
-907 Reduced 9.43%
8,714 $630,000
Q4 2018

Jan 08, 2019

BUY
$65.56 - $74.27 $59,462 - $67,362
907 Added 10.41%
9,621 $706,000
Q4 2018

Jan 07, 2019

SELL
$65.56 - $74.27 $59,462 - $67,362
-907 Reduced 9.43%
8,714 $630,000
Q3 2018

Oct 03, 2018

BUY
$60.81 - $73.36 $291,705 - $351,907
4,797 Added 99.44%
9,621 $706,000
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $10,241 - $11,578
-182 Reduced 3.64%
4,824 $289,000
Q4 2017

Feb 05, 2018

BUY
$53.68 - $57.47 $268,722 - $287,694
5,006
5,006 $286,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clarus Wealth Advisors Portfolio

Follow Clarus Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Clarus Wealth Advisors with notifications on news.